Encompass Health Co. (NYSE:EHC) Shares Sold by Massachusetts Financial Services Co. MA

Massachusetts Financial Services Co. MA trimmed its holdings in shares of Encompass Health Co. (NYSE:EHC) by 0.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,110,521 shares of the company’s stock after selling 623 shares during the quarter. Massachusetts Financial Services Co. MA owned approximately 1.10% of Encompass Health worth $102,557,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in EHC. Townsquare Capital LLC purchased a new position in Encompass Health during the third quarter valued at $405,000. Point72 Asia Singapore Pte. Ltd. lifted its stake in Encompass Health by 62.0% in the 3rd quarter. Point72 Asia Singapore Pte. Ltd. now owns 1,095 shares of the company’s stock valued at $106,000 after buying an additional 419 shares in the last quarter. Benjamin Edwards Inc. boosted its holdings in Encompass Health by 37.2% in the 3rd quarter. Benjamin Edwards Inc. now owns 6,298 shares of the company’s stock worth $609,000 after buying an additional 1,707 shares during the last quarter. IHT Wealth Management LLC purchased a new stake in Encompass Health during the 3rd quarter worth approximately $233,000. Finally, Morse Asset Management Inc acquired a new position in shares of Encompass Health during the third quarter valued at approximately $68,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Encompass Health Stock Performance

NYSE:EHC opened at $98.14 on Friday. Encompass Health Co. has a fifty-two week low of $78.53 and a fifty-two week high of $104.55. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05. The company has a 50 day moving average price of $99.25 and a 200 day moving average price of $97.67. The stock has a market capitalization of $9.88 billion, a P/E ratio of 22.00, a PEG ratio of 2.31 and a beta of 0.87.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. Equities research analysts forecast that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be issued a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.69%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health’s dividend payout ratio (DPR) is currently 15.25%.

Insider Buying and Selling

In other news, CAO Andrew L. Price sold 5,042 shares of the company’s stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total transaction of $495,578.18. Following the sale, the chief accounting officer now owns 69,164 shares of the company’s stock, valued at approximately $6,798,129.56. This represents a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.10% of the stock is owned by insiders.

Analysts Set New Price Targets

Several brokerages recently commented on EHC. KeyCorp boosted their price target on Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a research report on Monday, February 10th. William Blair reiterated an “outperform” rating on shares of Encompass Health in a research report on Friday, February 7th. Royal Bank of Canada restated an “outperform” rating and set a $110.00 price target on shares of Encompass Health in a research report on Tuesday, February 11th. StockNews.com lowered shares of Encompass Health from a “buy” rating to a “hold” rating in a research note on Thursday. Finally, Barclays upped their price target on Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a research report on Friday, February 7th. One investment analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $107.67.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.